Ketamine ameliorated PTSD symptoms by reducing protein and gene expression levels of the GSK-3β pathway, thereby improving anxiety-like behaviour in SPS-exposed rats (Hu et al. 2023). The gene discussed is GSK3B; the disease is Anxiety.